Business context and reporting period
GigCapital5, Inc. filed this unaudited Form 10-Q for the quarter and six months ended June 30, 2023. It was a SPAC with no operating business or revenue; the filing describes its proposed merger with QT Imaging, Inc., a medical-device company. GigCapital5 expected to be renamed QT Imaging Holdings, Inc. upon completion of the merger. The transaction had not closed as of the filing.
Financial results and condition
Amounts are in U.S. dollars. Because GigCapital5 had no operating business, conventional operating margins are not meaningful.
| Metric | Three months ended June 30, 2023 | Three months ended June 30, 2022 | Six months ended June 30, 2023 | Six months ended June 30, 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| General and administrative expense | $1.64 million | $0.97 million | $3.40 million | $1.59 million |
| Net loss | $1.42 million | $0.64 million | $2.89 million | $1.01 million |
| Net loss per non-redeemable share | $0.26 | $0.13 | $0.53 | $0.19 |
| Interest income from Trust Account | $368,259 | $300,140 | $811,539 | $317,653 |
- Cash and liquidity: Cash outside the Trust Account was $7,480 at June 30, versus $78,196 at December 31, 2022. Trust Account cash and marketable securities were $32.37 million, generally restricted for a business combination or redemptions. Management reported a $7.97 million working-capital deficit and substantial doubt about the company’s ability to continue as a going concern.
- Cash flow: For the first half of 2023, operating activities used $1.09 million; investing activities provided $10.01 million, largely reflecting Trust Account withdrawals; and financing activities used $8.99 million, primarily for public-share redemptions, partly offset by sponsor borrowings. Cash declined by $70,716 to $7,480.
- Debt and liabilities: At June 30, the Sponsor’s Extension Note had $1.36 million principal outstanding (carrying amount $1.30 million), and the convertible Working Capital Note had $1.00 million principal outstanding and a $1.00 million fair value. Total liabilities were $10.80 million. The notes are due upon a business combination or winding up; the Working Capital Note may be converted at the Sponsor’s option in a combination.
Material changes versus the prior comparable period
- Quarterly net loss more than doubled year over year, as general and administrative expense rose about 68%; for the first half, net loss was about 2.9 times the prior-year amount.
- Trust Account interest income increased substantially year over year, but did not offset higher expenses. First-half operating cash use increased from $366,391 in 2022 to $1.09 million in 2023.
- Public-share redemptions reduced redeemable shares to 3,019,001 at June 30 from 4,014,050 at December 31, 2022. The Trust Account balance fell to $32.37 million from $41.56 million.
- Wells Fargo waived $6.44 million of deferred underwriting fees in March 2023, contingent in effect on the proposed QT Imaging transaction proceeding; it retained entitlement to compensation in connection with an alternative combination if the proposed deal is terminated.
Outlook, risks and unusual items
- The company had a QT Imaging business-combination agreement dated December 8, 2022. Stockholder approval and other closing conditions remained relevant; the filing gives no operating guidance or forecast for the proposed combined company.
- The approved extension framework allowed the combination deadline to be extended by monthly deposits into the Trust Account, up to September 28, 2023. A July 25, 2023 subsequent event records a further $100,000 Sponsor deposit and an extension through August 28, 2023. Failure to complete a combination by the applicable deadline would require winding up and redeeming public shares.
- Management said available cash outside the Trust Account might be insufficient to fund operations through the extension period. It intended to manage expenses and could seek further Sponsor funding, but such funding was not assured. The filing expressly states that liquidity constraints and possible mandatory liquidation raise substantial doubt about going concern.
- The company’s shares moved from the NYSE to Nasdaq in April 2023 after falling below an NYSE continued-listing standard; separated warrants and units traded OTC. The filing warns that Nasdaq might not list the post-combination securities because initial listing standards are more rigorous.
- Additional risks include redemptions and financing needs, potential dilution from equity or debt issued for the transaction, uncertain economic and market conditions, and the possibility the proposed merger does not close. The company reported no material legal proceedings, no off-balance-sheet arrangements, and effective disclosure controls as of June 30.
Most important facts for investors to verify
- Whether the QT Imaging merger closed, obtained required approvals, and met its transaction conditions and applicable extension deadline.
- Trust Account proceeds remaining after redemptions, taxes, and any subsequent extension deposits, and the funds actually available to the combined company at closing.
- How the Sponsor notes, deferred underwriting fees, transaction costs, and any new financing will be settled; verify the potential dilution and conversion terms.
- Whether the post-combination securities satisfied Nasdaq initial listing requirements and what became of the warrants and units trading OTC.
- The going-concern disclosure: only $7,480 of unrestricted cash was reported at quarter-end, with a $7.97 million working-capital deficit and reliance on Sponsor support.